Cargando…
TERT Promoter Alterations in Glioblastoma: A Systematic Review
SIMPLE SUMMARY: Glioblastoma is the most common malignant primary brain tumor in adults. Glioblastoma accounts for 2 to 3 cases per 100,000 persons in North America and Europe. Glioblastoma classification is now based on histopathological and molecular features including isocitrate dehydrogenase (ID...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962450/ https://www.ncbi.nlm.nih.gov/pubmed/33800183 http://dx.doi.org/10.3390/cancers13051147 |
_version_ | 1783665472316637184 |
---|---|
author | Olympios, Nathalie Gilard, Vianney Marguet, Florent Clatot, Florian Di Fiore, Frédéric Fontanilles, Maxime |
author_facet | Olympios, Nathalie Gilard, Vianney Marguet, Florent Clatot, Florian Di Fiore, Frédéric Fontanilles, Maxime |
author_sort | Olympios, Nathalie |
collection | PubMed |
description | SIMPLE SUMMARY: Glioblastoma is the most common malignant primary brain tumor in adults. Glioblastoma accounts for 2 to 3 cases per 100,000 persons in North America and Europe. Glioblastoma classification is now based on histopathological and molecular features including isocitrate dehydrogenase (IDH) mutations. At the end of the 2000s, genome-wide sequencing of glioblastoma identified recurrent somatic genetic alterations involved in oncogenesis. Among them, the alterations in the promoter region of the telomerase reverse transcriptase (TERTp) gene are highly recurrent and occur in 70% to 80% of all glioblastomas, including glioblastoma IDH wild type and glioblastoma IDH mutated. This review focuses on recent advances related to physiopathological mechanisms, diagnosis, and clinical implications. ABSTRACT: Glioblastoma, the most frequent and aggressive primary malignant tumor, often presents with alterations in the telomerase reverse transcriptase promoter. Telomerase is responsible for the maintenance of telomere length to avoid cell death. Telomere lengthening is required for cancer cell survival and has led to the investigation of telomerase activity as a potential mechanism that enables cancer growth. The aim of this systematic review is to provide an overview of the available data concerning TERT alterations and glioblastoma in terms of incidence, physiopathological understanding, and potential therapeutic implications. |
format | Online Article Text |
id | pubmed-7962450 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79624502021-03-17 TERT Promoter Alterations in Glioblastoma: A Systematic Review Olympios, Nathalie Gilard, Vianney Marguet, Florent Clatot, Florian Di Fiore, Frédéric Fontanilles, Maxime Cancers (Basel) Systematic Review SIMPLE SUMMARY: Glioblastoma is the most common malignant primary brain tumor in adults. Glioblastoma accounts for 2 to 3 cases per 100,000 persons in North America and Europe. Glioblastoma classification is now based on histopathological and molecular features including isocitrate dehydrogenase (IDH) mutations. At the end of the 2000s, genome-wide sequencing of glioblastoma identified recurrent somatic genetic alterations involved in oncogenesis. Among them, the alterations in the promoter region of the telomerase reverse transcriptase (TERTp) gene are highly recurrent and occur in 70% to 80% of all glioblastomas, including glioblastoma IDH wild type and glioblastoma IDH mutated. This review focuses on recent advances related to physiopathological mechanisms, diagnosis, and clinical implications. ABSTRACT: Glioblastoma, the most frequent and aggressive primary malignant tumor, often presents with alterations in the telomerase reverse transcriptase promoter. Telomerase is responsible for the maintenance of telomere length to avoid cell death. Telomere lengthening is required for cancer cell survival and has led to the investigation of telomerase activity as a potential mechanism that enables cancer growth. The aim of this systematic review is to provide an overview of the available data concerning TERT alterations and glioblastoma in terms of incidence, physiopathological understanding, and potential therapeutic implications. MDPI 2021-03-08 /pmc/articles/PMC7962450/ /pubmed/33800183 http://dx.doi.org/10.3390/cancers13051147 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Systematic Review Olympios, Nathalie Gilard, Vianney Marguet, Florent Clatot, Florian Di Fiore, Frédéric Fontanilles, Maxime TERT Promoter Alterations in Glioblastoma: A Systematic Review |
title | TERT Promoter Alterations in Glioblastoma: A Systematic Review |
title_full | TERT Promoter Alterations in Glioblastoma: A Systematic Review |
title_fullStr | TERT Promoter Alterations in Glioblastoma: A Systematic Review |
title_full_unstemmed | TERT Promoter Alterations in Glioblastoma: A Systematic Review |
title_short | TERT Promoter Alterations in Glioblastoma: A Systematic Review |
title_sort | tert promoter alterations in glioblastoma: a systematic review |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962450/ https://www.ncbi.nlm.nih.gov/pubmed/33800183 http://dx.doi.org/10.3390/cancers13051147 |
work_keys_str_mv | AT olympiosnathalie tertpromoteralterationsinglioblastomaasystematicreview AT gilardvianney tertpromoteralterationsinglioblastomaasystematicreview AT marguetflorent tertpromoteralterationsinglioblastomaasystematicreview AT clatotflorian tertpromoteralterationsinglioblastomaasystematicreview AT difiorefrederic tertpromoteralterationsinglioblastomaasystematicreview AT fontanillesmaxime tertpromoteralterationsinglioblastomaasystematicreview |